Bakhu Holdings, Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2021
March 17, 2021 at 04:01 pm IST
Share
Bakhu Holdings, Corp. announced earnings results for the second quarter ended January 31, 2021. For the second quarter, the company announced operating loss was USD 922,821 compared to USD 70,438 a year ago. Net loss was USD 933,929 compared to USD 73,481 a year ago. For the half year, operating loss was USD 1.977 million compared to USD 102,745 a year ago. Net loss was USD 1.994 million compared to USD 108,213 a year ago. Basic loss per share from continuing operations was USD 0.01.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.